101 - Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA): A Randomized, Placebo-Controlled Trial

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Helen C. Stankiewicz Karita, MD, MSc

Acting Assistant Professor, Infectious Diseases
University of Washington
Seattle, Washington, United States

AM

Amalia Magaret, PhD

University of Washington
Seattle, Washington, United States
JS

Jeffrey Schouten, MD

University of Washington
Seattle, Washington, United States
CM

Constance Mao, MD

University of Washington
Seattle, Washington, United States
WH

Warner Huh, MD

University of Alabama at Birmingham
Birmingham, Washington, United States
VG

Verena Grieco, MD

University of Washington
Seattle, Washington, United States
MS

Matthew Seymour, BS, MPH

University of Washington
Seattle, Washington, United States
DV

Dana Varon, ARNP

University of Washington
Seattle, Washington, United States
DD

David Doody, MSc

University of Washington
Seattle, Washington, United States
Lx

Long Fu xi, PhD

University of Washington
Seattle, Washington, United States
DG

Denise Galloway, PhD

University of Washington
Seattle, Washington, United States
Anna Wald, MD, MPH

Professor
University of Washington
Seattle, Washington, United States
MM

Margaret Madeleine, PhD

University of Washington
Seattle, Washington, United States